177Lu-DOTA-StarPEG-ACUPA3

N/A

Report date: 2025/06/11 11:25:13
NME

Base Information

Drug Name177Lu-DOTA-StarPEG-ACUPA3
Drug Alias Name[177Lu]-PEG-(DOTA)1-(ACUPA)3
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsSPECT contrast agent
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaProlynx Llc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A